A detailed history of Psi Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Psi Advisors, LLC holds 5,950 shares of BMY stock, worth $323,204. This represents 0.09% of its overall portfolio holdings.

Number of Shares
5,950
Previous 6,730 11.59%
Holding current value
$323,204
Previous $279,000 10.04%
% of portfolio
0.09%
Previous 0.09%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$39.66 - $51.75 $30,934 - $40,365
-780 Reduced 11.59%
5,950 $307,000
Q2 2024

Jul 23, 2024

BUY
$40.25 - $52.99 $27,933 - $36,775
694 Added 11.5%
6,730 $279,000
Q1 2024

Apr 24, 2024

BUY
$47.98 - $54.4 $9,404 - $10,662
196 Added 3.36%
6,036 $327,000
Q4 2023

Feb 01, 2024

SELL
$48.48 - $57.85 $18,228 - $21,751
-376 Reduced 6.05%
5,840 $299,000
Q3 2023

Oct 13, 2023

BUY
$57.89 - $64.73 $63,157 - $70,620
1,091 Added 21.29%
6,216 $360,000
Q2 2023

Jul 21, 2023

BUY
$63.71 - $70.74 $30,134 - $33,460
473 Added 10.17%
5,125 $327,000
Q1 2023

Apr 25, 2023

BUY
$65.71 - $74.53 $65 - $74
1 Added 0.02%
4,652 $322,000
Q4 2022

Jan 19, 2023

SELL
$68.48 - $81.09 $276,453 - $327,360
-4,037 Reduced 46.47%
4,651 $0
Q3 2022

Oct 20, 2022

SELL
$0.13 - $76.84 $505 - $298,830
-3,889 Reduced 30.92%
8,688 $618,000
Q2 2022

Jul 18, 2022

SELL
$72.62 - $79.98 $44,516 - $49,027
-613 Reduced 4.65%
12,577 $968,000
Q1 2022

Apr 20, 2022

SELL
$61.48 - $73.72 $133,165 - $159,677
-2,166 Reduced 14.11%
13,190 $963,000
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $40,168 - $46,827
-749 Reduced 4.65%
15,356 $958,000
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $14,970 - $17,535
-253 Reduced 1.55%
16,105 $953,000
Q2 2021

Aug 10, 2021

BUY
$61.91 - $67.42 $15,848 - $17,259
256 Added 1.59%
16,358 $1.09 Million
Q1 2021

May 11, 2021

BUY
$59.34 - $66.74 $162,354 - $182,600
2,736 Added 20.47%
16,102 $1.02 Million
Q4 2020

Feb 08, 2021

BUY
$57.74 - $65.43 $97,927 - $110,969
1,696 Added 14.53%
13,366 $829,000
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $23,086 - $25,583
402 Added 3.57%
11,670 $703,000
Q2 2020

Aug 04, 2020

BUY
$54.82 - $64.09 $128,881 - $150,675
2,351 Added 26.37%
11,268 $662,000
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $35,588 - $51,718
-767 Reduced 7.92%
8,917 $497,000
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $476,549 - $621,615
9,684 New
9,684 $621,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Psi Advisors, LLC Portfolio

Follow Psi Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Psi Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Psi Advisors, LLC with notifications on news.